Arch Therapeutics's total assets for Q were $1.40M, a decrease of -9.25% from the previous quarter. ARTH total liabilities were $4.57M for the fiscal quarter, a 4.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.